OmniAb (OABI) Change in Acquisitions & Divestments (2022 - 2025)
OmniAb (OABI) reported Change in Acquisitions & Divestments of -$39.7 million for Q4 2025, down 373.86% year-over-year from $14.5 million in Q4 2024, and down 200.0% on a QoQ basis from $39.7 million in Q3 2025.
OmniAb (OABI) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$39.7 million in Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 373.86% year-over-year to -$39.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$9.4 million (down 115.3% YoY) and the FY2025 annual result came in at $90000.0, down 99.88% from the prior year.
- Change in Acquisitions & Divestments retreated to -$39.7 million in Q4 2025 per OABI's latest filing, from $39.7 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $62.2 million in Q3 2024 and bottomed at -$39.7 million in Q4 2025.
- The 4-year median for Change in Acquisitions & Divestments is $4.0 million (2023), against an average of $6.3 million.
- The widest annual swing landed in 2024, when Change in Acquisitions & Divestments jumped 1919.5%; it then sank 373.86% in 2025.
- Tracing OABI's Change in Acquisitions & Divestments over 4 years: stood at $70000.0 in 2022, then jumped by 925.71% to $718000.0 in 2023, then jumped by 1919.5% to $14.5 million in 2024, then sank by 373.86% to -$39.7 million in 2025.
- Per Business Quant, the three latest OABI Change in Acquisitions & Divestments figures stand at -$39.7 million (Q4 2025), $39.7 million (Q3 2025), and -$9.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.71 Mn |
| Dec 31, 2025 | -39.71 Mn |
| Sep 30, 2025 | 39.71 Mn |
| Sep 30, 2025 | 39.71 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Mar 31, 2025 | 9.50 Mn |
| Mar 31, 2025 | 9.50 Mn |
| Dec 31, 2024 | 14.50 Mn |
| Dec 31, 2024 | 14.50 Mn |
| Sep 30, 2024 | 62.19 Mn |
| Sep 30, 2024 | 62.19 Mn |
| Jun 30, 2024 | -24.69 Mn |
| Jun 30, 2024 | -24.69 Mn |
| Mar 31, 2024 | 26.00 Mn |
| Mar 31, 2024 | 26.00 Mn |
| Dec 31, 2023 | 718,000.00 |
| Dec 31, 2023 | 718,000.00 |
| Sep 30, 2023 | -27.29 Mn |
| Sep 30, 2023 | -27.29 Mn |
| Jun 30, 2023 | 26.00 Mn |
| Jun 30, 2023 | 26.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 70,000.00 |
| Dec 31, 2022 | 70,000.00 |